Your session is about to expire
← Back to Search
Diagnostic Ultrasound for Breast Cancer Screening
Study Summary
This trial uses a commercial ultrasound transducer and near infrared optical imaging sensors mounted on a hand-held ultrasound probe to co-register ultrasound and optical images of the breast. This unique approach has demonstrated its potential to accurately differentiate between malignant and benign breast abnormalities, as well as predict and monitor the response of breast cancer to neoadjuvant chemotherapy (NAC).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have breast implants.I have had radiation on the breast opposite to the one currently affected.My lesion is in the dark area around my nipple.I am a woman over 18 with a breast abnormality needing a biopsy.I chose a biopsy over imaging for my probably benign breast finding.I have other areas in my breast that will be imaged during my biopsy.I have small skin or near-skin lesions under 1 cm.You are pregnant.
- Group 1: Phase 2: Prospective Trial
- Group 2: Phase I - Training Set
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the participation rate of this research endeavor?
"Affirmative. Clinicaltrials.gov provides evidence that this research is currently admitting participants; it was initially posted on December 13th 2018 and edited most recently in December 2021. The team responsible for the trial seeks to recruit 335 individuals from a single location."
Are there any vacancies left for participants of this experiment?
"Enrolment is still open for this medical trial, first posted on December 13th 2018 and updated as recently as December 7th 2021."
Share this study with friends
Copy Link
Messenger